BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31201454)

  • 1. LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression.
    Liu T; Peng F; Yu J; Tan Z; Rao T; Chen Y; Wang Y; Liu Z; Zhou H; Peng J
    Anal Bioanal Chem; 2019 Aug; 411(20):5079-5088. PubMed ID: 31201454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidomic Signatures for Colorectal Cancer Diagnosis and Progression Using UPLC-QTOF-ESI
    Răchieriu C; Eniu DT; Moiş E; Graur F; Socaciu C; Socaciu MA; Hajjar NA
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33799830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A plasma lipidomics strategy reveals perturbed lipid metabolic pathways and potential lipid biomarkers of human colorectal cancer.
    Shen S; Yang L; Li L; Bai Y; Cai C; Liu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():41-48. PubMed ID: 29028617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing metabolic changes in human colorectal cancer.
    Williams MD; Zhang X; Park JJ; Siems WF; Gang DR; Resar LM; Reeves R; Hill HH
    Anal Bioanal Chem; 2015 Jun; 407(16):4581-95. PubMed ID: 25943258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Verification of Two Novel Differentially Expressed Proteins from Non-neoplastic Mucosa and Colorectal Carcinoma Via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry.
    Bai Y; Wang J; Gao Z; Dai E
    Pathol Oncol Res; 2020 Apr; 26(2):967-976. PubMed ID: 30927204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the Lipid Profile in Patients with Colorectal Cancer in Advanced Stages.
    de Figueiredo Junior AG; Serafim PVP; de Melo AA; Felipe AV; Lo Turco EG; da Silva IDCG; Forones NM
    Asian Pac J Cancer Prev; 2018 May; 19(5):1287-1293. PubMed ID: 29802561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
    Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
    BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid profiling for early diagnosis and progression of colorectal cancer using direct-infusion electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
    Li F; Qin X; Chen H; Qiu L; Guo Y; Liu H; Chen G; Song G; Wang X; Li F; Guo S; Wang B; Li Z
    Rapid Commun Mass Spectrom; 2013 Jan; 27(1):24-34. PubMed ID: 23239314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal Cancer Detection Using Targeted LC-MS Metabolic Profiling.
    Djukovic D; Zhang J; Raftery D
    Methods Mol Biol; 2018; 1765():229-240. PubMed ID: 29589312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer.
    Zhao Z; Xiao Y; Elson P; Tan H; Plummer SJ; Berk M; Aung PP; Lavery IC; Achkar JP; Li L; Casey G; Xu Y
    J Clin Oncol; 2007 Jul; 25(19):2696-701. PubMed ID: 17602074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
    Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
    BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
    Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
    [No Abstract]   [Full Text] [Related]  

  • 13. A conjunctive lipidomic approach reveals plasma ethanolamine plasmalogens and fatty acids as early diagnostic biomarkers for colorectal cancer patients.
    Liu T; Tan Z; Yu J; Peng F; Guo J; Meng W; Chen Y; Rao T; Liu Z; Peng J
    Expert Rev Proteomics; 2020 Mar; 17(3):233-242. PubMed ID: 32306783
    [No Abstract]   [Full Text] [Related]  

  • 14. Altered plasma levels of decanoic acid in colorectal cancer as a new diagnostic biomarker.
    Crotti S; Agnoletto E; Cancemi G; Di Marco V; Traldi P; Pucciarelli S; Nitti D; Agostini M
    Anal Bioanal Chem; 2016 Sep; 408(23):6321-8. PubMed ID: 27379390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
    Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
    Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STUDY OF LIPID BIOMARKERS OF PATIENTS WITH POLYPS AND COLORECTAL CÂNCER.
    Serafim PVP; Figueiredo AG; Felipe AV; Turco EGL; Silva IDCGD; Forones NM
    Arq Gastroenterol; 2019; 56(4):399-404. PubMed ID: 31800736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum fatty acid profiling of colorectal cancer by gas chromatography/mass spectrometry.
    Kondo Y; Nishiumi S; Shinohara M; Hatano N; Ikeda A; Yoshie T; Kobayashi T; Shiomi Y; Irino Y; Takenawa T; Azuma T; Yoshida M
    Biomark Med; 2011 Aug; 5(4):451-60. PubMed ID: 21861667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in lipids composition and metabolism in colorectal cancer: a review.
    Pakiet A; Kobiela J; Stepnowski P; Sledzinski T; Mika A
    Lipids Health Dis; 2019 Jan; 18(1):29. PubMed ID: 30684960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of differential metabolic characteristics between tumor and normal tissue from colorectal cancer patients by gas chromatography-mass spectrometry.
    Ning W; Li H; Meng F; Cheng J; Song X; Zhang G; Wang W; Wu S; Fang J; Ma K; Yang J; Pei D; Dong F
    Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28475217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabonomics identifies serum metabolite markers of colorectal cancer.
    Tan B; Qiu Y; Zou X; Chen T; Xie G; Cheng Y; Dong T; Zhao L; Feng B; Hu X; Xu LX; Zhao A; Zhang M; Cai G; Cai S; Zhou Z; Zheng M; Zhang Y; Jia W
    J Proteome Res; 2013 Jun; 12(6):3000-9. PubMed ID: 23675754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.